News

Other news

Ground-breaking tech identifies cognitive diseases with high accuracy

By JLABS

Read full story
Other news

Distributed Bio announces a deal to identify pre-optimized antibodies using their SuperHuman antibody library platform

By JLABS

Read full story
Other news

Ontario-developed technology for screening variant libraries comes of age

By JLABS

Read full story
Other news

Hear Bill Martin, CSO of Blackthorn Therapeutics discuss how #digitalhealth and #pharma are intersecting for CNS drug development, in our latest podcast

By JLABS

Read full story
Other news

Arcturus Therapeutics expands collaboration with Takeda Pharmaceuticals

By JLABS

Read full story
Other news

BlueRock Therapeutics and Hootsuite Top the 2018 Narwhal List

By JLABS

Read full story
Other news

Alzheimer’s Drug One-Step Closer to Reality After Krembil Team Signs Major Development Deal

By JLABS

Read full story
Other news

Congratulations to the JLABS @ TMC Company, Corinnova, Inc. for coming in first place in the RESI San Francisco Innovation Challenge at the 2018 JP Morgan Conference

By JLABS

Read full story
Other news

Why weed tech is missing from CES 2018, even as the budding industry booms

By JLABS

Read full story
Other news

qīī Redefines the Oral Health Industry With Launch of Proprietary Tea Drinks

By JLABS

Read full story
Other news

Cyclica and Translatum Medicus inc (TMi) Announce Partnership to Advance Small Molecule Discovery for Age-Related Macular Degeneration

By JLABS

Read full story
Other news

It's been a big year for Tennessee science

By JLABS

Read full story
Other news

MedChart, Eve Medical part of HealthTech projects funded by $5.47 million from Ontario

By JLABS

Read full story
Other news

Servier and Treventis begin strategic research partnership in neurodegenerative diseases

By JLABS

Read full story
Other news

Alumni, Batu Biologics, has secured $1.3M in crowdfunding to develop its clinical stage tumor-angiogenesis targeting immunotherapy, ValloVax

By JLABS

Read full story